StocksMedium•4 November 2026•
1 min read
Pacific Biosciences Beats Q3 Earnings and Revenue Estimates
Key Facts
1Pacific Biosciences reported earnings per share that beat analyst estimates by $0.02.
2The company's revenue for the period exceeded market expectations.
Pacific Biosciences reported earnings per share that beat analyst estimates by $0.02 for the third quarter of 2026. According to Investing.com, the company's revenue for the period also exceeded market expectations.
The quarterly financial results for Pacific Biosciences showed a beat on both the top and bottom lines. This performance supports a bullish outlook for the biotech firm following the release of its fiscal data.